DAPSA versus cDAPSA: Do we need to use CRP?-Reference-Cited by-同舟云学术

DAPSA versus cDAPSA: Do we need to use CRP?

Published:2019-07-22 Issue:11 Volume:79 Page:e142-e142
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Gonçalves Rafaela Silva Guimarães^ORCID,de Almeida Martins Lays Miranda,de Ataide Mariz Henrique,Dantas Andrea Tavares,Duarte Angela Luzia Branco Pinto

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference5 articles.

1. Ideal target for psoriatic arthritis? Comparison of remission and low disease activity states in a real-life cohort

2. Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score

3. Modification of the Psoriatic Arthritis Disease Activity Score (PASDAS)

4. Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment

5. Inflammatory markers predict insulin sensitivity in active rheumatoid arthritis but not in psoriatic arthritis;Bellan;Reumatismo,2018

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intense symptoms of pain are associated with poor sleep, fibromyalgia, depression and sleep apnea in patients with rheumatoid arthritis and psoriatic arthritis. A register-based study;Joint Bone Spine;2024-09

2. Cross-sectional analysis of cardiovascular disease and risk factors in patients with spondyloarthritis: a real-life evidence from biostar nationwide registry;Rheumatology International;2024-02-06

3. Sex-specific differences in patients with psoriatic arthritis:a nationwide study from the Chinese Registry of Psoriatic Arthritis (CREPAR IV);Clinical Rheumatology;2024-01-10

5. Earlier clinical response predicts low rates of radiographic progression in biologic-naïve patients with active psoriatic arthritis receiving guselkumab treatment;Clinical Rheumatology;2023-10-03